Devyser Diagnostics AB () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

CellaVision AB

MedCap AB

Surgical Science Sweden AB

Bactiguard Holding AB

BONESUPPORT HOLDING AB

Devyser Diagnostics AB

Genovis AB

Smart Eye AB

Doxa AB

Xvivo Perfusion AB

Sedana Medical AB

Why is Devyser Diagnostics AB ?

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -23.17%, its profits have risen by 15.9%

Below par performance in long term as well as near term

Along with generating -23.17% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Devyser Diagnostics AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Devyser Diagnostics AB

-23.17%

-0.71

41.25%

OMX Stockholm 30

10.97%

0.59

18.59%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

27.99%

EBIT Growth (5y)

25.65%

EBIT to Interest (avg)

-31.88

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

0.56

Tax Ratio

3.56%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.55

EV to EBIT

-62.06

EV to EBITDA

-180.40

EV to Capital Employed

8.47

EV to Sales

9.05

PEG Ratio

Dividend Yield

ROCE (Latest)

-13.65%

ROE (Latest)

-13.49%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK 8.2 MM

ROCE(HY)

Highest at -2.39%

NET SALES(Q)

Highest at SEK 72 MM

OPERATING PROFIT(Q)

Highest at SEK 25.2 MM

OPERATING PROFIT MARGIN(Q)

Highest at 35 %

PRE-TAX PROFIT(Q)

Highest at SEK 16 MM

NET PROFIT(Q)

Highest at SEK 13.6 MM

EPS(Q)

Highest at SEK 0.82

-11What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -7.23 %

INTEREST(Q)

At SEK 2.1 MM has Grown at 75%

RAW MATERIAL COST(Y)

Grown by 5.97% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.81 times

Here's what is working for Devyser Diagnostics AB

Pre-Tax Profit

At SEK 16 MM has Grown at 433.33%

over average net sales of the previous four periods of SEK -4.8 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Net Profit

At SEK 13.6 MM has Grown at 315.87%

over average net sales of the previous four periods of SEK -6.3 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (SEK MM)

Operating Cash Flow

Highest at SEK 8.2 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Sales

Highest at SEK 72 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit

Highest at SEK 25.2 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin

Highest at 35 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at SEK 16 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit

Highest at SEK 13.6 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS

Highest at SEK 0.82

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Depreciation

Highest at SEK 7 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for Devyser Diagnostics AB

Interest

At SEK 2.1 MM has Grown at 75%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Debt-Equity Ratio

Highest at -7.23 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 3.81 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 5.97% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales